Exane Derivatives’s Clorox CLX Stock Holding History

Exane Derivatives’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$564	Hold	4	–	–	﹤0.01%	558
2022 Q1	$556	Hold	4	–	–	﹤0.01%	850
2021 Q4	$697	Hold	4	–	–	﹤0.01%	739
2021 Q3	$662	Hold	4	–	–	﹤0.01%	908
2021 Q2	$716	Hold	4	–	–	﹤0.01%	908
2021 Q1	$772	Hold	4	–	–	﹤0.01%	754
2020 Q4	$808	Hold	4	–	–	﹤0.01%	696
2020 Q3	$841	Sell	4 -2,177	-100%	-$485K	﹤0.01%	632
2020 Q2	$478K	Buy	+2,181	New	+$436K	0.13%	135
2018 Q4	–	Sell	-1	Closed	-$150	–	691
2018 Q3	$150	Sell	1 -470	-100%	-$66.8K	﹤0.01%	608
2018 Q2	$63.8K	Sell	471 -48	-9%	-$5.92K	0.01%	370
2018 Q1	$67.5K	Buy	519 +438	+541%	+$58.8K	0.01%	333
2017 Q4	$12.1K	Sell	81 -666	-89%	-$90.6K	﹤0.01%	393
2017 Q3	$98.5K	Buy	747 +376	+101%	+$50.5K	0.02%	262
2017 Q2	$49.4K	Sell	371 -129	-26%	-$17.4K	0.01%	314
2017 Q1	$67.4K	Buy	+500	New	+$64.8K	0.02%	253
2016 Q4	–	Sell	-61,642	Closed	-$7.72M	–	654
2016 Q3	$7.72M	Buy	+61,642	New	+$8.07M	1.16%	35
2015 Q2	–	Sell	-199,322	Closed	-$22M	–	528
2015 Q1	$22M	Buy	+199,322	New	+$21.6M	2.43%	13

Other funds holding CLX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Exane Derivatives's CLX Position: Q2 2022 in Review

Exane Derivatives held its Clorox (CLX) position steady in Q2 2022 at 4 shares worth $564. The position accounts for ﹤0.01% of the portfolio, ranked #558.

Exane Derivatives first reported a position in CLX in Q1 2015 and has held it in 18 quarters since. The position peaked at $22M in Q1 2015. 1,082 funds tracked by Wall St. Rank hold CLX as of Q2 2022.

Exane Derivatives held 4 shares of Clorox worth $564 as of Q2 2022.
Exane Derivatives left its Clorox share count unchanged in Q2 2022.
Clorox made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #558 holding.
Exane Derivatives first reported a position in Clorox in Q1 2015 and has held it in 18 quarters since.
Exane Derivatives's Clorox position peaked at $22M in Q1 2015.
1,082 funds tracked by Wall St. Rank held Clorox as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.